| REVIEW ARTICLE |
|
| Year : 2017 | Volume
: 8
| Issue : 1 | Page : 41-44 |
|
|
Development of statistics as a discipline for clinical research: Past, present, and future
Chitra Lele
Chief Scientific Officer, Ph.D, Sciformix Corporation, US
Correspondence Address:
Chitra Lele
Sciformix Technologies Pvt Ltd., Akruti Softech Park, Road No. 21, MIDC, Andheri, Mumbai . 400 093, Maharashtra, India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2229-3485.198548
|
|
|
This article traces the history and evolution of statistics in the era of evidence based medicine, and focuses on the Indian perspective of this growth of statistics as a discipline for clinical research. Statistics will assume a more inter disciplinary form. Use of software other than SAS likely to grow further. In India, innovative statistical methods will help propel the development of biosimilars. The future is exciting with statistics being used for real world evidence, development of biosimilars, mining of adverse event data and becoming a core function in medicinal product development and lifecycle maintenance. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
